CLDF Title
Contact Us | Bookmark
  HBV   HCC   HCV   HE   NASH   PBC   THROMBOCYTOPENIA
Centers of Educational Expertise  
Live CME Meetings Webcasts Slide Library Abstract Library Conference Highlights
Featured Programs
      IC-Hep
 
             
  Liver News - REUTERS   Congress Calendar   Physician Resources  
 
 
Liquid biopsy spots early liver cancer in patients with HBV infection
03-20-2019
REFILE-Stopping oral antiviral therapy in chronic hep B possible for some people
03-04-2019
Model finds bariatric surgery cost-effective in NASH
03-01-2019
Stopping oral antiviral therapy in chronic hep B possible for some people
02-28-2019
Whole grains might help protect against liver cancer
02-21-2019
View Complete News Library
 
 
View all Congresses
 
 
 
 
 
 
 
 
 
  Line  
  Featured Abstracts          
 
Bridging the access gap: Medicare ineligibility in people living with chronic hepatitis B
 
Spontaneous loss of surface antigen among adults living with chronic hepatitis B virus infection: a systematic review and pooled meta-analyses
 
A global meta-analysis on HIV, hepatitis C and hepatitis B among people who inject drugs - do gender differences vary by country-level indicators?
 
Antiviral therapy and the development of osteopenia/osteoporosis among Asians with chronic hepatitis B
 
Use of Ribavirin for Hepatitis C Treatment in the Modern Direct-acting Antiviral Era
 
Effect of Hepatitis C Treatment on Renal Function in Liver Transplant Patients
 
Integrating comprehensive hepatitis C virus care within a residential substance use disorder treatment program
 
Treating HCV Infection: It Doesn't Get Much Better Than This
 
Prevalence of Hepatitis C Virus Infection in US States and the District of Columbia, 2013 to 2016
 
The HCV care continuum: linkage to HCV care and treatment among patients at an urban health network, Philadelphia, PA
 
Hepatitis C in Pregnancy: A Unique Opportunity to Improve the Hepatitis C Cascade of Care
 
Short-Term Effects and Long-Term Cost-Effectiveness of Universal Hepatitis C Testing in Prenatal Care
 
The successful scale-up of direct-acting antiviral hepatitis C treatments will benefit from concerted investments in implementation science
 
 
Impact of Substance Use Disorder on the Rate of Sustained Virological Response in Veterans With Chronic Hepatitis C Treated With Direct-Acting Antivirals
 
Safety and efficacy of glecaprevir/pibrentasvir in patients with chronic hepatitis C genotypes 1-6 receiving opioid substitution therapy
 
Efficacy and Safety of Ruzasvir 60 mg and Uprifosbuvir 450 mg for 12 Weeks in Adults With Chronic Hepatitis C Virus Genotype 1, 2, 3, 4, or 6 Infection
 
National Trends and Long-term Outcomes of Liver Transplant for Alcohol-Associated Liver Disease in the United States
 
Predisposing Conditions to Pediatric Hepatocellular Carcinoma and Association with Outcomes: Single-Center Experience
 
Direct-acting antiviral agents and risk of hepatocellular carcinoma: is it still a clinical dilemma?
 
Racial and Geographic Disparities in Hepatocellular Carcinoma Outcomes
 
Weighing the benefits of hepatocellular carcinoma surveillance against potential harms
 
Medical treatment of advanced hepatocellular carcinoma patients: the issue is not the right drug, but the right patient
 
Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased ?-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial
 
Regorafenib: a promising treatment for hepatocellular carcinoma
 
Regorafenib treatment for patients with hepatocellular carcinoma who progressed on sorafenib-A cost-effectiveness analysis
 
Is there increased risk of hepatocellular carcinoma recurrence in liver transplant patients with direct-acting antiviral therapy?
 
 
Hepatocellular carcinoma in non-cirrhotic liver: A comprehensive review
 
Cabozantinib: A Review in Advanced Hepatocellular Carcinoma
 
Lenvatinib for the treatment of unresectable hepatocellular carcinoma: evidence to date
 
Frailty Associated With Waitlist Mortality Independent of Ascites and Hepatic Encephalopathy in a Multi-Center Study
 
The Psychomotor Vigilance Task: Role in the Diagnosis of Hepatic Encephalopathy and Relationship with Driving Ability
 
 
          View All Abstracts  
  Line  
                               
 
HBV
Webcasts
Slide Library
Abstract Library
 
HCC
Slide Library
Abstract Library
 
 
HCV
Webcasts
Slide Library
Abstract Library
 
 
HE
Webcasts
Slide Library
Abstract Library
 
NASH
Webcasts
Slide Library
Abstract Library
 
 
PBC
Webcasts
Slide Library
Abstract Library
 
 
OTHER
Webcasts
Slide Library
   
   
 
About CLDF
Mission Statement
Board of Trustees
Board of Advisors/Faculty
CLDF Sponsors & Supporters
 
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
 
Centers of
Educational Expertise
Hepatology
Substance Use Disorder
             
CLDF Follow Us
   
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2019 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.